ZHANG Jianping  

  • Graduate Supervisor, Chief Pharmacist
  • Department: Pharmacy
  • Research Area: Traditional Chinese Medicine
  • Research Interests: Oncology pharmacy; Pharmaceutical administration; Comprehensive clinical evaluation of drugs
  • Contact: zhangjianping1997@126.com
  • M.S from Soochow University, 2012
  • B.S from Shanghai Medical College Fudan University, 1997
  • Deputy Director, Department of Pharmacy, Shanghai Sixth People's Hospital
  • Vice Chairwoman, Clinical Pharmacy Committee, Shanghai Rehabilitation Medicine Engineering Research Institute
  • Committee Member, Pharmacy Committee, China Medical Women's Association
  • Committee Member,  Clinical Pharmacy Branch, China International Exchange and Promotive Association for Medical and Health Care
  • Committee Member, Oncology Pharmacy Committee, Shanghai Anti-cancer Association
  • Committee Member,  Pharmacoeconomics Committee, Shanghai Pharmaceutical Association
  • Deputy Group Leader, Pharmacy Outpatient Group, Shanghai Pharmaceutical Association 
  • Group Leader, Science Popularization Group,Shanghai Licensed Pharmacist Association
  • Member of Editorial Board, Chinese Journal of Modern Applied Pharmacy
  1. Zhao X, Xu R, Zhang J#. Adherence to Analgesic Drugs and its Associated Factors among Patients with Cancer Pain: A Crosssectional Study in China. Am J Health Behav, 2023, doi: 10.5993/AJHB.47.1.4. 
  2. Zhang J,Yang Q,  Guo C#. Expert Consensus on Temporary Procurement of Novel Antineoplastic Drugs Based on Rapid Drug Evaluation in the Yangtze River Delta Region. China Pharmaceuticals, 2023, doi:10.3969 / j.issn.1006 -4931.2023.11.001 
  3. Xin B, Zhang J#. Application Effect of Integrated Medication Decision - Making System in the Antibiotics Medical Order Review in Inpatients. China Pharmaceuticals, 2023, doi:10.3969 / j.issn.1006 - 4931.2023.13.003
  4. Yang L, Zhang J#. Risk signal mining of ixazomib based on the database of FAERS. China Pharmacy, 2023, doi:10.6039/j.issn.1001-0408.2023.22.15
  5. Zhao X, Zhang J#. Standardized Construction and Practice of ″3 + 2 + 1″ Pharmacists - Managed Outpatient Clinic Based on Medical Alliance. China Pharmaceuticals, 2022, doi:10.3969 / j.issn.1006 - 4931.2022.22.002
  6. Zhang J, Xu R, Guo C#. The effectiveness of an independent anti-neoplastic medication therapy management system in ambulatory cancer patients. Transl Cancer Res, 2021, doi: 10.21037/tcr-20-3164.
  7. Zhao X, Xu R, Zhang J#. Impacts of Pharmacists-Managed Oncology Outpatient Clinic on Resolving Drug-Related Problems in Ambulatory Neoplasm Patients: A Prospective Study in China. Inquiry, 2021, doi: 10.1177/00469580211009662.
  8. Xu R, Zhang J#. Practice and efficiency of standardized construction of the oncology pharmacy outpatient service. Pharmaceutical Care and Research, 2021, doi: 10.5428/pcar20210608
  9. Yang Q, Zhang J, Guo C#. Distinct Metabolic Profile of Inhaled Budesonide and Salbutamol in Asthmatic Children during Acute Exacerbation. Basic Clin Pharmacol Toxicol, 2017, doi: 10.1111/bcpt.12686.
  10. Yang Q, Zhang J#. Construction of Integrated Medication Decision-making System of Real-time Intervention in Advance,In_x005f_x005f_x005f_x005f_x005f_x0002_teractive Review in the Matter and Afterward Comment and Analysis in Our Hospital.China Pharmacy, 2017, doi:10.6039/j.issn.1001-0408.2017.35.33
  1. [JianPing Zhang] (2020), “Pharmaceutical care system v1.0 for cancer patients with heart disease”, 2021SR0102940
  2. [JianPing Zhang] (2019), “Drug monitoring system V1.0 for patients with cancer pain”, 2020SR0022320